125 related articles for article (PubMed ID: 23278726)
1. 'Monster cell' melanoma with pulmonary metastasis and cyclin D1 amplification.
Hawryluk EB; Baran JL; Gerami P; Sepehr A
J Cutan Pathol; 2013 Jan; 40(1):61-5. PubMed ID: 23278726
[TBL] [Abstract][Full Text] [Related]
2. Malignant melanoma with monster cells showing massive cyclin D1 amplification.
Pouryazdanparast P; Newman M; Mafee M; Guitart J; Gerami P
Am J Dermatopathol; 2009 Jun; 31(4):402-3. PubMed ID: 19461251
[No Abstract] [Full Text] [Related]
3. An Unusual Case of Desmoplastic Melanoma With Monster Cells Imitating an Atypical Fibroxanthoma.
Ríos-Martín JJ; Pérez-Pérez M; Umbría-Jiménez S; Moreno-Ramírez D; Vallejo-Benítez A
Int J Surg Pathol; 2022 May; 30(3):313-316. PubMed ID: 34541940
[TBL] [Abstract][Full Text] [Related]
4. Homogeneous staining regions for cyclin D1, a marker of poor prognosis in malignant melanoma.
Gammon B; Ali L; Guitart J; Gerami P
Am J Dermatopathol; 2012 Jul; 34(5):487-90. PubMed ID: 22456513
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 is a candidate oncogene in cutaneous melanoma.
Sauter ER; Yeo UC; von Stemm A; Zhu W; Litwin S; Tichansky DS; Pistritto G; Nesbit M; Pinkel D; Herlyn M; Bastian BC
Cancer Res; 2002 Jun; 62(11):3200-6. PubMed ID: 12036934
[TBL] [Abstract][Full Text] [Related]
6. Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas.
Nai G; Marques M
Pathol Res Pract; 2011 Mar; 207(3):174-81. PubMed ID: 21300445
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
[TBL] [Abstract][Full Text] [Related]
8. Basaloid squamous cell carcinoma with 'monster' cells: a mimic of pleomorphic basal cell carcinoma.
Defty CL; Segen J; Carter JJ; Ahmed I; Carr RA
J Cutan Pathol; 2011 Apr; 38(4):354-6. PubMed ID: 21039745
[TBL] [Abstract][Full Text] [Related]
9. Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma.
Utikal J; Udart M; Leiter U; Peter RU; Krähn G
Int J Oncol; 2005 Mar; 26(3):597-605. PubMed ID: 15703813
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.
Requena C; Rubio L; Traves V; Sanmartín O; Nagore E; Llombart B; Serra C; Fernández-Serra A; Botella R; Guillén C
Histopathology; 2012 Nov; 61(5):899-909. PubMed ID: 22882594
[TBL] [Abstract][Full Text] [Related]
11. Copy number variations and clinical outcome in atypical spitz tumors.
Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
[TBL] [Abstract][Full Text] [Related]
12. Monster cells in malignant melanoma.
Boyd AS; Wu H; Shyr Y
Am J Dermatopathol; 2005 Jun; 27(3):208-10. PubMed ID: 15900123
[TBL] [Abstract][Full Text] [Related]
13. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
[TBL] [Abstract][Full Text] [Related]
14. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ.
Yamaura M; Takata M; Miyazaki A; Saida T
Arch Dermatol; 2005 Nov; 141(11):1413-8. PubMed ID: 16301388
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 homogeneous staining regions by fluorescent in situ hybridization: a possible indicator of aggressive behavior in melanomas.
Gerami P; Guitart J; Martini M; Wayne JD; Kuzel T
Arch Dermatol; 2008 Sep; 144(9):1235-6. PubMed ID: 18794480
[No Abstract] [Full Text] [Related]
16. Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation.
Burnworth B; Popp S; Stark HJ; Steinkraus V; Bröcker EB; Hartschuh W; Birek C; Boukamp P
Oncogene; 2006 Jul; 25(32):4399-412. PubMed ID: 16547504
[TBL] [Abstract][Full Text] [Related]
17. Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma.
Flørenes VA; Faye RS; Maelandsmo GM; Nesland JM; Holm R
Clin Cancer Res; 2000 Sep; 6(9):3614-20. PubMed ID: 10999753
[TBL] [Abstract][Full Text] [Related]
18. [A silent-growing and fast-killing melanoma in a teenager].
Uguen A; Talagas M; Quintin-Roué I; Abasq C; Coat C; Charles-Pétillon F; De Braekeleer M; Marcorelles P
Ann Pathol; 2012 Aug; 32(4):254-8. PubMed ID: 23010398
[TBL] [Abstract][Full Text] [Related]
19. Distinctive clinical and histologic features in cutaneous melanoma with copy number gains in 8q24.
Pouryazdanparast P; Cowen DP; Beilfuss BA; Haghighat Z; Guitart J; Rademaker A; Gerami P
Am J Surg Pathol; 2012 Feb; 36(2):253-64. PubMed ID: 22020039
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas.
Bachmann IM; Straume O; Akslen LA
Int J Oncol; 2004 Dec; 25(6):1559-65. PubMed ID: 15547691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
